GMABLARGE

Genmab A/S

HealthcareBiotechnology
$27.06
$0.01(-2.98%)
52W$18.89
$35.43
Updated May 7, 12:00 AM
RSI55
RS Rating33/99
Beta0.94
Volatility35%
F-Score5/9
Mkt Cap$16.7B
WEAKENING

Price Action

5Y Daily
50 DMA150 DMA200 DMA

Technical Summary

WEAKENING

Genmab A/S is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is weak (RS Rating: 33), showing significant lag compared to the market leaders. Earnings contraction of 67% provides fundamental context to the price action. A decisive close above the 200-day moving average is required to signal a potential trend reversal.

Relative Strength
33
out of 99
Lagging
Trend Score
1/4
Minervini Criteria
WEAKENING
Risk (Beta)
0.94
vs S&P 500
MARKET
52W Position
49%
from 52W low
Lower Half
Trend & Momentum Analysis

Trend Template (Minervini)

WEAKENING1/4 Criteria Met
CriterionValueStatus
Price > 50 SMA$27.25
50 SMA > 100 SMA$29.64
100 SMA > 150 SMA$30.05
150 SMA > 200 SMA$28.90

Price vs Moving Averages

PeriodValueSpreadSignal
20 SMA$27.51-1.64%BELOW
50 SMA$27.25-0.72%BELOW
100 SMA$29.64-8.69%BELOW
150 SMA$30.05-9.96%BELOW
200 SMA$28.90-6.36%BELOW

Price Performance

1D-3.0%
1W+2.0%
1M-2.1%
3M-12.3%
6M-5.6%
YTD-15.0%
1Y+31.4%
3Y-12.5%
52-Week Trading Range49% from low
$27.06
52W Low$18.89
52W High$35.43

Technical Indicators

RSI (14)NEUTRAL
54.9
305070
VCP ScoreCOOL
4/10
Base depth: 23.3%

Risk Profile

Beta
0.94
52W Vol
35%
ATR
$0.78
Max DD (1Y)
-29%

Volume Analysis

Today
3.49M
50D Avg
1.58M
Vol Ratio
2.21x
Liquidity
MODERATE

Earnings Momentum

Q4'24+518%
$5.99
Q1'25-85%
$0.31
Q2'25+58%
$3.42
Q3'25-67%
$0.65
Fundamentals & Growth

Growth Trends

Compounded Sales Growth

10 Years:+38.14%
5 Years:+32.03%
3 Years:+36.75%
TTM:+21.03%

Compounded Profit Growth

10 Years:+36.77%
5 Years:+28.99%
3 Years:+39.42%
TTM:+45.85%

Stock Price CAGR

10 Years:+5.95%
5 Years:-6.27%
3 Years:-12.48%
1 Year:+31.36%

Return on Equity

10Y Avg:21.9%
5Y Avg:20.6%
3Y Avg:19.9%
Last Year:114.2%

Key Metrics

Market Cap$16.7B
Gross Margin95.4%
Net Margin36.4%
Piotroski F-Score5/9

Frequently Asked Questions

Is GMAB in an uptrend right now?

GMAB has a trend score of 1/4 based on Minervini's Stage Analysis. Currently showing broken structure - 1 of 4 trend criteria are met.

Is GMAB overbought or oversold?

GMAB's RSI (14) is 55. The stock is in neutral territory, neither overbought nor oversold.

Is GMAB outperforming the market?

GMAB has a Relative Strength (RS) Rating of 33 out of 99. GMAB is currently lagging the broader market.

Where is GMAB in its 52-week range?

GMAB is trading at $27.06, which is 76% of its 52-week high ($35.43) and 49% above its 52-week low ($18.89).

How volatile is GMAB?

GMAB has a Beta of 0.94 and 52-week volatility of 35%. It's less volatile than the S&P 500 - generally more stable.

Disclaimer: Data is for informational purposes only. May be delayed or contain errors. Past performance does not guarantee future results. This is not financial advice. Always conduct your own research and consult professionals before making investment decisions.